The suspected mitochondrial pathology of OPA3 defects can explain the clinical–biochemical hallmarks of OPA3-related 3-MGA-uria; optic atrophy, neuropathy and increased urinary excretion of 3-MGA and 3-MGR. Here, OPA3 is linked to neuropathy.